This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (161)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Randomized Controlled Trial  • Alert me on articles by topic

A 3-Year, Randomized, Placebo-Controlled, Double-blind Study

Karel Pavelká, MD, PhD; Jindriska Gatterová, MD; Marta Olejarová, MD; Stanislav Machacek, MD; Giampaolo Giacovelli, PhD; Lucio C. Rovati, MD

Arch Intern Med. 2002;162:2113-2123.

Background  Conventional symptomatic treatments for osteoarthritis do not favorably affect disease progression. The aim of this randomized, placebo-controlled trial was to determine whether long-term (3-year) treatment with glucosamine sulfate can modify the progression of joint structure and symptom changes in knee osteoarthritis, as previously suggested.

Methods  Two hundred two patients with knee osteoarthritis (using American College of Rheumatology criteria) were randomized to receive oral glucosamine sulfate, 1500 mg once a day, or placebo. Changes in radiographic minimum joint space width were measured in the medial compartment of the tibiofemoral joint, and symptoms were assessed using the algo-functional indexes of Lequesne and WOMAC (Western Ontario and McMaster Universities).

Results  Osteoarthritis was of mild to moderate severity at enrollment, with average joint space widths of slightly less than 4 mm and a Lequesne index score of less than 9 points. Progressive joint space narrowing with placebo use was -0.19 mm (95% confidence interval, -0.29 to -0.09 mm) after 3 years. Conversely, there was no average change with glucosamine sulfate use (0.04 mm; 95% confidence interval, -0.06 to 0.14 mm), with a significant difference between groups (P = .001). Fewer patients treated with glucosamine sulfate experienced predefined severe narrowings (>0.5 mm): 5% vs 14% (P = .05). Symptoms improved modestly with placebo use but as much as 20% to 25% with glucosamine sulfate use, with significant final differences on the Lequesne index and the WOMAC total index and pain, function, and stiffness subscales. Safety was good and without differences between groups.

Conclusion  Long-term treatment with glucosamine sulfate retarded the progression of knee osteoarthritis, possibly determining disease modification.

From the Department of Medicine and Rheumatology, Charles University (Dr Pavelká), and the Institute of Rheumatology (Drs Pavelká, Gatterová, Olejarová, and Machacek), Prague, Czech Republic; and the Department of Clinical Pharmacology, Rotta Research Laboratorium, Monza, Italy (Drs Giacovelli and Rovati).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of strontium ranelate on spinal osteoarthritis progression
Bruyere et al.
Ann Rheum Dis 2008;67:335-339.
ABSTRACT | FULL TEXT  

Effect of Glucosamine Sulfate on Hip Osteoarthritis: A Randomized Trial
Rozendaal et al.
ANN INTERN MED 2008;148:268-277.
ABSTRACT | FULL TEXT  

Predictors of symptomatic response to glucosamine in knee osteoarthritis: an exploratory study
Bennett et al.
Br. J. Sports. Med. 2007;41:415-419.
ABSTRACT | FULL TEXT  

Superiority of the Lyon schuss view over the standing anteroposterior view for detecting joint space narrowing, especially in the lateral tibiofemoral compartment, in early knee osteoarthritis
Merle-Vincent et al.
Ann Rheum Dis 2007;66:747-753.
ABSTRACT | FULL TEXT  

Current role of glucosamine in the treatment of osteoarthritis
Reginster et al.
Rheumatology (Oxford) 2007;46:731-735.
ABSTRACT | FULL TEXT  

EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Zhang et al.
Ann Rheum Dis 2007;66:377-388.
ABSTRACT | FULL TEXT  

A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients
Buckland-Wright et al.
Rheumatology (Oxford) 2007;46:257-264.
ABSTRACT | FULL TEXT  

A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip
Luyten et al.
Ann Rheum Dis 2007;66:99-106.
ABSTRACT | FULL TEXT  

Oral Glucosamine for 6 Weeks at Standard Doses Does Not Cause or Worsen Insulin Resistance or Endothelial Dysfunction in Lean or Obese Subjects
Muniyappa et al.
Diabetes 2006;55:3142-3150.
ABSTRACT | FULL TEXT  

Glucosamine Supplementation Accelerates Early but Not Late Atherosclerosis in LDL Receptor-Deficient Mice
Tannock et al.
J. Nutr. 2006;136:2856-2861.
ABSTRACT | FULL TEXT  

Effect of Glucosamine on Glucose Control
Stumpf and Lin
The Annals of Pharmacotherapy 2006;40:694-698.
ABSTRACT | FULL TEXT  

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
Clegg et al.
NEJM 2006;354:795-808.
ABSTRACT | FULL TEXT  

Nutritional supplements for knee osteoarthritis--still no resolution.
Hochberg
NEJM 2006;354:858-860.
FULL TEXT  

Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness
Biggee et al.
Ann Rheum Dis 2006;65:222-226.
ABSTRACT | FULL TEXT  

Chondroprotective drugs in degenerative joint diseases
Verbruggen
Rheumatology (Oxford) 2006;45:129-138.
ABSTRACT | FULL TEXT  

Comparison of quantitative and semiquantitative indicators of joint space narrowing in subjects with knee osteoarthritis
Mazzuca et al.
Ann Rheum Dis 2006;65:64-68.
ABSTRACT | FULL TEXT  

Is it time for more rheumatologists to embrace osteoarthritis?
Birrell et al.
Rheumatology (Oxford) 2005;44:829-830.
FULL TEXT  

Glucosamine Long-Term Treatment and the Progression of Knee Osteoarthritis: Systematic Review of Randomized Controlled Trials
Poolsup et al.
The Annals of Pharmacotherapy 2005;39:1080-1087.
ABSTRACT | FULL TEXT  

A naturalistic study of the determinants of health related quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal anti-inflammatory drugs
Rabenda et al.
Ann Rheum Dis 2005;64:688-693.
ABSTRACT | FULL TEXT  

Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis
Shikhman et al.
Ann Rheum Dis 2005;64:89-94.
ABSTRACT | FULL TEXT  

Use of complementary medicines for osteoarthritis--a prospective study
Zochling et al.
Ann Rheum Dis 2004;63:549-554.
ABSTRACT | FULL TEXT  

The use of conventional and complementary treatments for knee osteoarthritis in the community
Jordan et al.
Rheumatology (Oxford) 2004;43:381-384.
ABSTRACT | FULL TEXT  

Non-surgical treatment of osteoarthritis: a half century of "advances"
Brandt
Ann Rheum Dis 2004;63:117-122.
FULL TEXT  

This house believes that we should advise our patients with osteoarthritis of the knee to take glucosamine
Manson and Rahman
Rheumatology (Oxford) 2004;43:100-101.
FULL TEXT  

Minerva
BMJ 2003;327:E182-182.
FULL TEXT  

A topical cream containing glucosamine and chondroitin sulphate reduced joint pain in osteoarthritis of the knee
Reginster
Evid. Based Med. 2003;8:154-154.
FULL TEXT  

Structural and Symptomatic Efficacy of Glucosamine and Chondroitin in Knee Osteoarthritis: A Comprehensive Meta-analysis
Richy et al.
Arch Intern Med 2003;163:1514-1522.
ABSTRACT | FULL TEXT  

Investigating CAM
Hoffer
CMAJ 2003;168:1527-1528.
FULL TEXT  

Robin Goodfellow (42-1)
Rheumatology (Oxford) 2003;42:196-196.
FULL TEXT  

Minerva
BMJ 2002;325:1046-1046.
FULL TEXT  

Is glucosamine worth taking for osteoarthritis?
DTB 2002;40:81-83.
ABSTRACT | FULL TEXT  

Complementary medicine and the scientific method: Mainstreaming proven "alternative" therapies
Baumrucker
AM J HOSP PALLIAT CARE 2002;19:369-371.